Total nucleic acid isolation kit
The Total Nucleic Acid Isolation Kit is a product designed for the extraction and purification of both DNA and RNA from a variety of sample types. The kit utilizes a spin column-based method to efficiently capture and isolate total nucleic acids, which can then be used for further downstream applications.
Lab products found in correlation
32 protocols using total nucleic acid isolation kit
Nucleic Acid Extraction from Nasal Swabs
Nucleic Acid Extraction from Centrifuged Samples
SARS-CoV-2 RT-PCR Detection Protocol
Quantification of HCV RNA in Cell Culture
HPV DNA Detection and Genotyping
Whole-Blood Nucleic Acid Extraction and qPCR
18S rRNA
41 (link). Genomic DNA from the same extraction was used to test for human haemoglobinopathies haemoglobin S and C
42 (link).
MERS-CoV Detection by rRT-PCR
MERS-CoVs were detected in specimens using real-time reverse transcription (rRT)-PCR. Extracted RNAs were screened by targeting the upE region, and positive results were confirmed by a subsequent amplification of orf1a using a PowerChek MERS Real-Time PCR kit (Kogene Biotech, Seoul, South Korea). All rRT-PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) with a total reaction volume of 20 μL (15 μL of PCR reaction mixture and 5 μL of template RNA). The thermocycling conditions included a reverse transcription reaction for 30 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 sec at 95°C and 60 sec at 60°C. A positive viral template control and a nontemplate control were included in each run. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified simultaneously as an internal control to monitor PCR inhibition. A positive result was identified by a well-defined exponential fluorescence curve that crossed the defined threshold at ≤35 cycles in both the upE and ORF1a assays.
Quantifying Mosquito-Borne Viral Transmission
Multiplex PCR for Respiratory Pathogens
A previously described multiplex real-time PCR assay was used for detection of 15 different viruses (adenovirus, bocavirus, coronavirus 229E, HKU1, NL63 and OC43, enterovirus, influenza A and B, human metapneumovirus, parainfluenza 1–3, rhinovirus and respiratory syncytial virus (RSV)) and 5 different bacterial species (Bordetella pertussis, Chlamydia pneumoniae, H. influenzae, Mycoplasma pneumoniae and S. pneumoniae) [11 (link)]. A PCR Cycle threshold (Ct)-value of <35 was considered a positive result with values of Ct<30 indicating high levels of nucleic acids. Pneumococci were identified both by detection of the lytA gene included in the multiple pathogen panel, mentioned above and by occurrence of the cpsA gene included in the serotyping multiplex real-time PCR panel (see below). A sample was considered positive for pneumococci if one or both of these genes were detected. For analysis of pneumococci at high levels, either lytA or cpsA, or both, were detected at Ct levels below 30.
Influenza Virus Detection from Nasopharyngeal Swabs
Example 1
Samples are taken from nasopharyngeal swabs (NPS) of patients presenting flu-like symptoms and the samples are each placed into approximately 3 ml of viral transport medium (for example M4, M4RT, M5, or M6 media (Remel), UVT media (Becton Dickinson), or UTM media (Copan)). Samples were refrigerated for transport at 2-8° C., and stored at that temperature for up to approximately 72 hours before processing. Samples which needed longer storage were stored at ≤−70° C. Nucleic acids were extracted from samples using standard laboratory methods to isolate nucleic acids (e.g., MagNA Pure LC System using the Total Nucleic Acid Isolation Kit (Roche) or the NucliSENS easyMAG System using the Automated Magnetic Extraction Reagents (bioMérieux)). A positive control sample is included which has a target sequence for each of the tested viral strains. That is, if the swine H1N1 influenza A virus is to be tested, a swine H1N1 influenza A virus target sequence is included. Here, the positive controls were pooled RNA transcript from a portion of an HA gene or of an NP gene for each of the subtypes of influenza. In addition, a negative control including the viral transport medium, but not including a target sequence, and Internal Controls were extracted alongside the samples.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!